FDC Ltd has received USFDA approval for its ANDA of Fluconazole tablets, a generic version of Pfizer’s Diflucan. The antifungal drug, with U.S. sales of $43 million annually, will boost FDC’s presence in the American generics market and expand its anti-infective portfolio.
Show moreStay Ahead – Explore Now! Dharan Infra-EPC Clears Dues, Seeks Exit From Insolvency Process
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
